Hyaluronic Acid Market

Hyaluronic Acid Market Insights

The Hyaluronic Acid market is projected to grow at a significant CAGR during the forecast period. Extensive use of hyaluronic acid in dermatology is expected to have a positive impact on the market. This growth can be attributed to the growing number of people opting for aesthetic non-surgical procedures and growing geriatric population.

Rising disposable income of individuals has led to consumers spending more on aesthetic non-surgical procedures such as hyaluronic acid injections. Factors such as the high cost of the procedure and side-effects associated with hyaluronic acid are some factors expected to hinder the market up to a certain extent.

Hyaluronic Acid Market: By Application

The Hyaluronic Acid market can be segmented based on basis of application into dermal fillers, osteoarthritis, ophthalmic and vesicoureteral reflux among others. The osteoarthritis segment can be segmented further into a single injection, three injections, and five injections among others. The dermal fillers segment is expected to hold the largest market share in terms of revenue during the forecast period. The desire to look healthy and young and high effectiveness of dermal fillers is inclining men and women to opt for this procedure.

The osteoarthritis segment is also expected to grow at a substantial CAGR. Within the segment, three injection segment is projected to hold the largest market share in terms of revenue, while the single injection segment is expected to grow at the highest CAGR. The ophthalmic applications segment is expected to grow at the fastest rate owing to the growing incidence of cataract, glaucoma, dry eyes and age-related macular degeneration.

Hyaluronic Acid Market: Regional Insights

North America is expected to dominate the hyaluronic acid market, with the U.S. being the major contributor. High disposable income of the population and their awareness about aging is expected to drive the market in the region. The Asia Pacific region is projected to register high growth rate in the coming years. Japan is expected to contribute a major share to the growth in Asia Pacific region due to its high geriatric population.

Hyaluronic Acid Market: End-Use Landscape

The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase electrochromic material over the coming years. Some companies which are currently using hyaluronic acid and are likely to purchase it in future such as Shiseido, Proctor & Gamble Co and Unilever among others.

Hyaluronic Acid Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Hyaluronic Acid Market: Share & Competitor Analysis

Some of the key players operating in the Hyaluronic Acid markets are Allergan, Inc.; Sanofi (Genzyme); Salix Pharmaceuticals; Seikagaku Corporation; Galderma S.A., Zimmer Holdings, Inc.; Smith & Nephew Plc; Ferring Pharmaceuticals, Inc.; Anika Therapeutics, Inc.; and F. Hoffmann-La Roche Ltd.

Please note: This is not an exhaustive list of companies profiled in the report.

In 2016, Genzyme Corporation received FDA approval for its single injection treatment. Presence of high-molecular-weight polymers of hyaluronic acid in the product is used as a lubricant to reduce the pain caused by osteoarthritis.

In March 2016, Anika Therapeutics launched its viscosupplement Cignal which is a combination of viscosupplement and steroids that help alleviate knee pain

In 2015, Actavis acquired Allegran, which a manufacturer of hyaluronic acid based ophthalmic dermatologic and aesthetic products.